ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 251190 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 251190; 2) Community: the network communities that were significantly associated with the response to NSC 251190; 3) Molecule: the relationships between components within communities and NSC 251190; 4) MDR: the compounds that were significantly associated with the NSC 251190.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0446159312763235 0.29934866
NSC 735318 Null 0.0446159312763235 0.29463206
NSC 736116 6-(3-Amonopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0446159312763235 0.37223444
NSC 737613 Null 0.0446159312763235 0.35362287
NSC 740259 Null 0.0446159312763235 0.57085799
NSC 740602 Null 0.0446159312763235 0.52805866
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0446159312763235 0.19062815
NSC 756304 GW678313X 0.0446159312763235 -0.24218088
NSC 758664 Sirolimus [USAN] 0.0446159312763235 -0.13586372
NSC 94600 Camptothecin 0.0446159312763235 0.070265193
Total:56  Current:45    [First] [Prev] [Next] [Last]